Epithelial Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Epithelial Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-11-19Clinical Trial Update: Bevacizumab and Trabectedin +/- Carboplatin in Advanced Ovarian Cancer [Phase 2]
Phase 2 trial assessing bevacizumab and trabectedin with or without carboplatin in recurrent ovarian epithelial cancer.
-
CLINICAL_TRIALS trial_result · 2019-11-06Clinical Trial Update: Efficacy of HIPEC in the Treatment of Advanced-Stage Epithelial Ovarian Cancer After Cytoreductive Surgery [Phase 3]
A Phase 3 clinical trial evaluating the efficacy of HIPEC following cytoreductive surgery for advanced epithelial ovarian cancer (including …
-
CLINICAL_TRIALS trial_result · 2019-10-08Clinical Trial Update: Granulocyte Colony Stimulating Factor for for the Prevention of Febrile Neutropenia in Epithelial Ovarian Cancer [Phase 3]
Phase 3 trial update evaluating Granulocyte Colony Stimulating Factor for prevention of febrile neutropenia in epithelial ovarian cancer.
-
CLINICAL_TRIALS trial_result · 2019-09-26Clinical Trial Update: VTX-2337 and Pegylated Liposomal Doxorubicin (PLD) in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer [Phase 2]
Phase 2 trial evaluating VTX-2337 with pegylated liposomal doxorubicin in recurrent or persistent epithelial ovarian, fallopian tube, or pri…
-
CLINICAL_TRIALS trial_result · 2019-08-30Clinical Trial Update: Phase III Trial of Stage I Ovarian Cancer After Surgery [Phase 3]
Phase III trial update for stage I ovarian cancer after surgery is currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-08-13Clinical Trial Update: GANNET53: Ganetespib in Metastatic, p53-mutant, Platinum-resistant Ovarian Cancer [Phase 1, Phase 2]
Clinical trial update for ganetespib (GANNET53) in metastatic p53-mutant platinum-resistant ovarian cancer; trial terminated with posted res…
-
CLINICAL_TRIALS trial_result · 2019-04-16Clinical Trial Update: MESO-CAR T Cells Therapy for Relapsed and Refractory Epithelial Ovarian Cancer [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating MESO-CAR T cell therapy for relapsed and refractory epithelial ovarian cancer. Status not disclosed in…
-
CLINICAL_TRIALS trial_result · 2019-01-31Clinical Trial Update: Study of Anti-Mesothelin Car NK Cells in Epithelial Ovarian Cancer [EARLY_Phase 1]
An early-phase study evaluating anti-mesothelin CAR NK cells for epithelial ovarian cancer is underway; sponsorship is Allife Medical Scienc…
-
CLINICAL_TRIALS trial_result · 2018-11-14Clinical Trial Update: Long-acting G-CSF for Febrile Neutropenia [Phase 3]
Phase 3 trial update on a long-acting G-CSF for febrile neutropenia in patients with epithelial ovarian cancer; status not disclosed.
-
CLINICAL_TRIALS trial_result · 2018-08-21Clinical Trial Update: Hyperthermic Intraperitoneal Chemotherapy With Paclitaxel in Advanced Ovarian Cancer [Phase 3]
Phase 3 trial evaluating hyperthermic intraperitoneal chemotherapy with paclitaxel in advanced epithelial ovarian cancer.
-
CLINICAL_TRIALS trial_result · 2018-07-27Clinical Trial Update: Phase 1 Study of NY-ESO-1 Overlapping Peptides in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 1]
Phase 1 study evaluating NY-ESO-1 overlapping peptides in epithelial ovarian, fallopian tube, or primary peritoneal cancer completed with re…
-
CLINICAL_TRIALS trial_result · 2018-05-22Clinical Trial Update: YKL-40 in Serum Samples From Patients With Newly Diagnosed Stage III-IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer Receiving Chemotherapy
A terminated clinical trial update investigating the serum biomarker YKL-40 in patients with newly diagnosed stage III-IV ovarian epithelial…
-
CLINICAL_TRIALS trial_result · 2018-01-24Clinical Trial Update: Efficacy of HIPEC as NACT and Postoperative Chemotherapy in the Treatment of Advanced-Stage Epithelial Ovarian Cancer [Phase 3]
A Phase 3 clinical trial evaluating HIPEC as neoadjuvant chemotherapy and postoperative chemotherapy for advanced epithelial ovarian cancer …
-
CLINICAL_TRIALS trial_result · 2017-12-08Clinical Trial Update: Ovarian Cancer Vaccine for Patients Who Have Progressed During the CAN-003 Study [Phase 2]
Phase 2 trial update on Prima BioMed's ovarian cancer vaccine for patients who progressed during CAN-003, with results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-11-21Clinical Trial Update: Veliparib and Radiation Therapy in Treating Patients With Advanced Solid Malignancies With Peritoneal Carcinomatosis, Epithelial Ovarian, Fallopian, or Primary Peritoneal Cancer [Phase 1]
Phase 1 trial evaluating veliparib in combination with radiation therapy in adults with advanced solid tumors featuring peritoneal carcinoma…
-
CLINICAL_TRIALS trial_result · 2017-10-19Clinical Trial Update: Plasma ctDNA Detection in Diagnosis of Epithelial Ovarian Cancer.
A completed clinical trial evaluating plasma ctDNA detection as a diagnostic tool for epithelial ovarian cancer. The study status is COMPLET…
-
CLINICAL_TRIALS trial_result · 2017-07-21Clinical Trial Update: Combination Study Of SB-485232 (Interleukin 18) And Doxil For Advanced Stage Epithelial Ovarian Cancer [Phase 1]
A completed Phase 1 trial evaluating the safety of combining SB-485232 (interleukin-18) with Doxil (liposomal doxorubicin) in advanced epith…
-
CLINICAL_TRIALS trial_result · 2017-06-28Clinical Trial Update: Safety and Efficacy Clinical Study of SNS-595 in Patients With Platinum-Resistant Ovarian Cancer [Phase 2]
A Phase 2 trial evaluating SNS-595 in platinum-resistant epithelial ovarian cancer has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2017-05-31Clinical Trial Update: Study on Neutropenia Induced by Adjuvant Paclitaxel/Carboplatin Chemotherapy in Patients With Epithelial Ovarian Cancer
Clinical trial update notes neutropenia observed in patients with epithelial ovarian cancer receiving adjuvant paclitaxel/carboplatin chemot…
-
CLINICAL_TRIALS trial_result · 2017-02-10Clinical Trial Update: Live After an Epithelial Ovarian Cancer: Multidisciplinary Assessment of Effects and Long-term Remission in Patients Needs. [NA]
Completed clinical trial update on epithelial ovarian cancer describing multidisciplinary assessment and observations related to long-term r…
-
CLINICAL_TRIALS trial_result · 2016-12-14Clinical Trial Update: Cvac as Maintenance Treatment in Patients With Epithelial Ovarian Cancer in Complete Remission Following First-line Chemotherapy or Second-line Treatment [Phase 2]
Phase 2 trial evaluating CVac as maintenance therapy in epithelial ovarian cancer patients in complete remission after first-line or second-…
-
CLINICAL_TRIALS trial_result · 2016-12-08Clinical Trial Update: Cisplatin Induction With Paclitaxel Consolidation for Stage III-IV Epithelial Ovarian and Primary Peritoneal Cancer [Phase 2]
Phase II trial assessing cisplatin induction with paclitaxel consolidation for stage III-IV epithelial ovarian cancer and primary peritoneal…
-
CLINICAL_TRIALS trial_result · 2016-09-22Clinical Trial Update: Belotecan Versus Topotecan for Recurrent Ovarian Cancer: A Randomized, Open-label, Parallel-group Phase IIb Trial [Phase 2]
A randomized Phase IIb trial comparing belotecan with topotecan for recurrent epithelial ovarian cancer has completed.
-
CLINICAL_TRIALS trial_result · 2016-08-04Clinical Trial Update: Ovarian Cancer Vaccine for Patients in Remission [Phase 2]
Phase 2 trial update for an ovarian cancer vaccine in patients in remission; the study is completed and results were posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-05-12Clinical Trial Update: A Study of MM-121 With Paclitaxel in Platinum Resistant/ Refractory Advanced Ovarian Cancers [Phase 2]
Phase 2 study evaluating MM-121 (seribantumab) in combination with paclitaxel for platinum-resistant/refractory advanced ovarian, fallopian …